Pramipexole Dihydrochloride Extended-Release
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
71034-002 -
Package NDC
71034-002-30 -
Application number
ANDA212797 -
SPL ID
c4ddb97d-cba5-9f6b-e053-2a95a90a4956 -
SPL set ID
1cbd8ddf-4fc1-4cd0-906d-a55a4b8b1c3c -
UNII
3D867NP06J -
RxCUI
901541 -
RxCUI
901546
What the source publishes
- Labeler
- Xiamen LP Pharmaceutical Co., Ltd.
- Active ingredients
- Pramipexole Dihydrochloride
- Form
- TABLET, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Pramipexole Dihydrochloride Extended-Release",
"splId": "c4ddb97d-cba5-9f6b-e053-2a95a90a4956",
"labels": [
{
"setId": "1cbd8ddf-4fc1-4cd0-906d-a55a4b8b1c3c",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1cbd8ddf-4fc1-4cd0-906d-a55a4b8b1c3c",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1cbd8ddf-4fc1-4cd0-906d-a55a4b8b1c3c"
}
],
"routes": [
"ORAL"
],
"labeler": "Xiamen LP Pharmaceutical Co., Ltd.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71034-002-30)",
"package_ndc": "71034-002-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20210611"
}
],
"productId": "71034-002_c4ddb97d-cba5-9f6b-e053-2a95a90a4956",
"useDomain": "unknown",
"dosageForm": "TABLET, EXTENDED RELEASE",
"productNdc": "71034-002",
"deaSchedule": null,
"genericName": "Pramipexole Dihydrochloride",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "PRAMIPEXOLE DIHYDROCHLORIDE",
"strength": ".375 mg/1"
}
],
"applicationNumber": "ANDA212797",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20210611",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0371034003306",
"0371034002309"
],
"unii": [
"3D867NP06J"
],
"rxcui": [
"901541",
"901546"
],
"spl_set_id": [
"1cbd8ddf-4fc1-4cd0-906d-a55a4b8b1c3c"
],
"manufacturer_name": [
"Xiamen LP Pharmaceutical Co., Ltd."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:71034-002_c4ddb97d-cba5-9f6b-e053-2a95a90a4956"